title: Quality of life through therapeutic advances. Pharmaceutical company news: Ipsen N.V.
abstract: IPSEN is the Belgian subsidiary of the independent European pharmaceutical company Beaufour Ipsen, founded in 1929 by Dr. Henri Beaufour. With an expanding international presence, the group invests almost 20% of group turnover in research and development of high technology ethical products. Beaufour Ipsen R & D's fundamental goal is quality of life for patients with a special emphasis on homeostatic regulation, achieving the optimal efficacy versus tolerance ratio.
mesh_terms: D018931:Antineoplastic Agents, Hormonal / Q000737:chemistry / Q000627:therapeutic use; D015195:Drug Design; D004345:Drug Industry; D005060:Europe; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000523:psychology; D011788:Quality of Life; D017329:Triptorelin Pamoate / Q000737:chemistry / Q000627:therapeutic use
chemical_list: D018931:Antineoplastic Agents, Hormonal; D017329:Triptorelin Pamoate